F. Fuchs

发表

Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on vero cells or on primary monkey kidney cells

F. de Fraipont, L. Mallet, F. Pelloquin, 1997, Journal of medical virology.

Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde

J. Bailly, M. Chambon, H. Peigue-Lafeuille, 1997, Applied and environmental microbiology.

Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome

H. Kopecká, F. Fuchs, M. Aymard, 1996, Journal of clinical microbiology.

Use of the polymerase chain reaction with a murine model of picornavirus-induced myocarditis

H. Kopecká, F. Fuchs, M. Aymard, 1993, Journal of clinical microbiology.

Use of non-neutralizing monoclonal antibodies in an ELISA for intratypic differentiation of 28 echovirus type 25 clinical isolates.

J. Bailly, H. Peigue-Lafeuille, F. Fuchs, 1992, Journal of virological methods.

New Generation of Cell Culture Assay for Smallpox Vaccine Potency

F. Fuchs, I. Leparc-Goffart, M. Tissier, 2003, Journal of Clinical Microbiology.

A new portable virus concentrator for use in the field

F. Fuchs, M. Aymard, M. Bartoli, 1996 .

Use of cRNA digoxigenin-labelled probes for detection of enteroviruses in humans and in the environment.

H. Kopecká, F. Fuchs, M. Aymard, 1993, Journal of virological methods.

Acute, chronic and persistent enterovirus and poliovirus infections: detection of viral genome by seminested PCR amplification in culture-negative samples.

F. Fuchs, M. Aymard, I. Leparc, 1994, Molecular and cellular probes.

Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies

M. Chambon, H. Peigue-Lafeuille, F. Fuchs, 1990, Journal of clinical microbiology.

Inactivated rabies vaccine control and release: use of an ELISA method.

C. Jallet, P. Perrin, N. Tordo, 2003, Biologicals : journal of the International Association of Biological Standardization.

Development of an in vitro potency test for tetanus vaccines: an immunoassay based on Hc fragment determination.

F. Fuchs, B. Poirier, M. Gal, 2002, Developments in biologicals.

Postpolio syndrome: poliovirus persistence is involved in the pathogenesis

B. Lina, H. Kopecká, F. Fuchs, 1999, Journal of Neurology.

Exposure to enteroviruses and hepatitis A virus among divers in environmental waters in France, first biological and serological survey of a controlled cohort

F. Fuchs, M. Aymard, D. Lamarque, 1994, Epidemiology and Infection.

Specific detection of enteroviruses in clinical samples by molecular hybridization using poliovirus subgenomic riboprobes

H. Kopecká, F. Fuchs, M. Aymard, 1990, Journal of clinical microbiology.

Quantitative detection of RT activity by PERT assay: feasibility and limits to a standardized screening assay for human vaccines.

F. Fuchs, S. Morgeaux, M. André, 2000, Biologicals : journal of the International Association of Biological Standardization.

Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.

F. Fuchs, I. Leparc-Goffart, J. Crance, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

In vitro potency assay for hepatitis A vaccines: development of a unique economical test.

F. Fuchs, S. Morgeaux, B. Poirier, 2000, Biologicals : journal of the International Association of Biological Standardization.

Quality control of biotechnology-derived vaccines: technical and regulatory considerations.

F. Fuchs, 2002, Biochimie.

Validation of an ultrafiltration process to concentrate viruses from large volumes of water

F. Fuchs, M. Aymard, M. Bartoli, 1993 .

Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration.

H. Fleury, F. Fuchs, I. Leparc-Goffart, 2005, Biologicals (Print).

Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.

F. Fuchs, C. Milne, A. Daas, 2003, Pharmeuropa bio.

In vitro potency assay for yellow fever vaccines: comparison of three vero cell lines sources.

F. Fuchs, F. Garnier, J. Fournier-Caruana, 2000, Biologicals : journal of the International Association of Biological Standardization.

Search for Poliovirus in Specimens from Patients with the Post‐Polio Syndrome

H. Kopecká, F. Fuchs, M. Aymard, 1995, Annals of the New York Academy of Sciences.